Literature DB >> 28107038

Prevalence of and Factors Associated with Sarcopenia in Korean Cancer Survivors: Based on Data Obtained by the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2011.

Eun Young Kim1, Kirang Kim2, Young Saing Kim3, Hee Kyung Ahn3, Yu Mi Jeong1, Jeong Ho Kim1, Won-Jun Choi4.   

Abstract

Using a representative dataset from the Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011, we analyzed anthropometric and dual-energy X-ray absorptiometry (DXA)-determined body composition findings for 493 cancer survivors (mean age a61.1 ± 12.6 years; 35.7% male). A much higher proportion of men (30.1%) than women (0.6%) met the criteria of sarcopenia. Subjects with a history of lung cancer, genitourinary cancer, or gastric cancer were prone to develop sarcopenia (31.6%, 26.3%, and 21.4%, respectively). Furthermore, sarcopenia was more prevalent among elderly (≥65 years; P < 0.001), those with a lower BMI level (<23 kg/m2; P < 0.001), heavy drinker (P = 0.012), or smoker (P < 0.001), and those with inadequate intakes of protein (P = 0.017) and vitamin A (P = 0.024). Multivariable logistic analyses revealed sarcopenia was significantly associated with male gender (odds ratio [OR], 68.14; 95% CI, 15.52-299.13), a BMI of <23 kg/m2 (OR 35.93, 95% CI, 8.24-156.67), and inadequate protein intake (OR 3.07, 95% CI, 1.30-7.22); these factors are significant predictors of sarcopenia in Korean cancer survivors.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28107038     DOI: 10.1080/01635581.2017.1267776

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  6 in total

1.  Prevalence and related factors of sarcopenia in newly diagnosed cancer patients.

Authors:  Utku Oflazoglu; Ahmet Alacacioglu; Umut Varol; Yuksel Kucukzeybek; Tarik Salman; Halil Taskaynatan; Yasar Yildiz; Ozlem Ozdemir; MustafaOktay Tarhan
Journal:  Support Care Cancer       Date:  2019-06-03       Impact factor: 3.603

2.  Chemotherapy-induced sarcopenia in newly diagnosed cancer patients: Izmir Oncology Group (IZOG) study.

Authors:  Utku Oflazoglu; Ahmet Alacacioglu; Umut Varol; Yuksel Kucukzeybek; Tarik Salman; Halil Taskaynatan; Yasar Yildiz; Seray Saray; M Oktay Tarhan
Journal:  Support Care Cancer       Date:  2019-11-22       Impact factor: 3.603

3.  Prevalence of low skeletal muscle quantity and quality and their associated factors in patients before allogeneic hematopoietic stem cell transplantation.

Authors:  Shinya Yoshida; Goro Sakurai; Tetsutaro Yahata
Journal:  Intern Emerg Med       Date:  2021-08-13       Impact factor: 3.397

4.  Integrated Analysis of DNA Methylation and Biochemical/Metabolic Parameter During the Long-Term Isolation Environment.

Authors:  Yuan Quan; Fengji Liang; Yuexing Zhu; Ying Chen; Zi Xu; Fang Du; Ke Lv; Hailong Chen; Lina Qu; Ruifeng Xu; Hong-Yu Zhang; Jianghui Xiong; Yinghui Li
Journal:  Front Physiol       Date:  2019-07-24       Impact factor: 4.566

5.  Sterol metabolism and protein metabolism are differentially correlated with sarcopenia in Asian Chinese men and women.

Authors:  Chun-Wei Li; Kang Yu; Ng Shyh-Chang; Guo-Xun Li; Song-Lin Yu; Hui-Jun Liu; Bo Yang; Zi-Yao Li; Yong-Jie Zhao; Long-Yu Xu; Jing Xu; Ling-Juan Jiang; Rong-Ji Liu; Xin-Yuan Zhang; Shao-Fei Li; Xiao-Wei Zhang; Hai-Yan Xie; Kang Li; Yi-Xiang Zhan; Min Cui; Hang-Bo Tao; Yao Li; Gao-Shan Liu; Ke-Min Ni; Dong-Jing Li
Journal:  Cell Prolif       Date:  2021-02-20       Impact factor: 6.831

6.  Does sarcopenia affect postoperative short- and long-term outcomes in patients with lung cancer?-a systematic review and meta-analysis.

Authors:  Yo Kawaguchi; Jun Hanaoka; Yasuhiko Ohshio; Keigo Okamoto; Ryosuke Kaku; Kazuki Hayashi; Takuya Shiratori; Akira Akazawa
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.